|
The
investigators constructed a mouse model of spontaneous autoimmune
thyroid disease (AITD, Hashimoto thyroiditis) by generation of
transgenic mice expressing a portion of an autoreactive T-cell
receptor (TCR) that specifically recognized an amino acid sequence of
human thyroid peroxidase (hTPO) (TPO535-551) obtained from
the thyroid gland of a patient with AITD. They did it by ligating the
gene sequence encoding the extracellular domain of the human TCR to
the gene sequence encoding the intracellular domain of the mouse TCR.
Within the sequence TPO535-551 are 2 overlapping epitopes
with distinctly different biologic properties: TPO536-547,
an agonistic stimulatory epitope, and TPO537-548, an
antagonistic epitope that can induce anergy in vitro.
TPO536-547 is a "cryptic" epitope displayed in
an inflamed thyroid gland. The human/mouse chimeric TCR was inserted
into the genome of a mouse in which the gene encoding V(D)J
recombinase had been inactivated (Rag1-/-,
Recombination-activating gene 1); Rag1-/- animals
are not able to synthesize antibodies or TCRs of the adaptive immune
system (OMIM 179615). Initially, the investigators demonstrated that
the hybrid human/mouse TCR was expressed on peripheral CD4+T
and CD8+T cells which proliferated in response to
TPO536-547. They also demonstrated that comparable mouse
and human TPO amino acid sequences were functionally similar.
TCR+-Rag1-/- mice developed
hypothyroidism spontaneously between 12-20 weeks of age. Their
thyroid glands revealed histological changes of thyroiditis with
infiltration by mononuclear cells, follicular destruction, and
apoptosis of thyroid epithelial cells (Figure). The authors concluded
that TCRs directed to epitopes of TPO alone could induce thyroid
inflammation.
Quaratino S, Badami E, Pang YY, et al. Degenerative self-reactive human
T-cell receptor causes spontaneous autoimmune disease in mice. Nature
Med 2004;10:920-6.
Editor’s
Comment: These investigators demonstrated that TCRs specific for
an epitope of TPO (TPO535-551) were able to produce AITD
in intact mice in the absence of mature B cells and autoantibodies to
TPO. The mechanisms by which the transgenic TCR detected the cryptic
epitope of mouse TPO and the thyroid epithelia were destroyed were
not identified. It is interesting to speculate that the conceptual
model utilized in these experiments might be applicable to other
autoimmune diseases and to the possible design of therapeutic
interventions targeted to a specific TCR. In an accompanying
editorial, McLachlan and Rapoport1 suggest that expansion
of the population of TCRs directed toward epitopes of TPO (eg,
TPO536-547) that enhance anergy might be able to prevent
thyroid inflammation and destruction.
Allen
W. Root, MD
References - (linked to )
- McLachlan SM, Rapoport B. Nature Med 2004.10:895-6.
|